NCT00152217View on ClinicalTrials.gov

Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

May 31, 2007

Study Completion Date

December 31, 2010

Conditions
Gastric Cancer
Interventions
DRUG

TS-1 (S-1)

80 mg of oral S-1 per square meter of body-surface area per day was given for 4 weeks and no chemotherapy was given for the following 2 weeks

PROCEDURE

Surgery

Stage II or III gastric cancer who underwent gastrectomy were assigned to surgery only

Trial Locations (1)

Unknown

National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku

All Listed Sponsors
lead

Taiho Pharmaceutical Co., Ltd.

INDUSTRY

NCT00152217 - Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC) | Biotech Hunter | Biotech Hunter